Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Statistical Considerations for the Design and Analysis of Pragmatic Trialsin Aging Research

Version 1 : Received: 7 May 2024 / Approved: 7 May 2024 / Online: 7 May 2024 (15:36:52 CEST)
Version 2 : Received: 4 June 2024 / Approved: 4 June 2024 / Online: 4 June 2024 (11:07:06 CEST)

A peer-reviewed article of this Preprint also exists.

Kammar-García, A.; Fernández-Urrutia, L.A.; Guevara-Díaz, J.A.; Mancilla-Galindo, J. Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research. Geriatrics 2024, 9, 75. Kammar-García, A.; Fernández-Urrutia, L.A.; Guevara-Díaz, J.A.; Mancilla-Galindo, J. Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research. Geriatrics 2024, 9, 75.

Abstract

Pragmatic trials aim toassess intervention efficacy in real-world settings, contrasting with explanatory trials conducted in controlled conditions. In aging research, pragmatic trials are important designs for the obtention of real-world evidence in elderly populations, often underrepresented in trials. In this review, we discuss statistical considerations from a frequentist approach to the design and analysis of pragmatic trials. Cluster randomization necessitates careful consideration of sample size calculation and analysis methods, especially regarding missing data and outcome variables. Mixed effects models and Generalized Estimating Equations (GEE) are both recommended for analysis, with tools available for sample size estimation. Multi-arm studies pose challenges in sample size calculation, requiring adjustment for design effects and consideration of multiple comparison correction methods. Secondary analyses are common but require caution due to reduced statistical power. Safety data collection methods should balance pragmatism and data quality. Overall, understanding statistical considerations is crucial for designing rigorous pragmatic trials evaluating interventions in elderly populations under real-world conditions.

Keywords

pragmatic clinical trials; aged; statistical analysis; geroscience; sample size; secondary data analysis

Subject

Biology and Life Sciences, Aging

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.